½ÃÀ庸°í¼­
»óǰÄÚµå
1263169

¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå ¸®Æ÷Æ®(2023³â)

Small Molecule API Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ¼¼°è ½ÃÀåÀº 2022³â 1,806¾ï 7,000¸¸ ´Þ·¯¿¡¼­ 2023³â±îÁö 7.2%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 1,936¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î´Â Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ ±Û·Î¹ú °æÁ¦ ȸº¹ÀÇ ±âȸ¸¦ ¹æÇØÇß½À´Ï´Ù. ÀÌ µÎ ³ª¶ó °£ÀÇ ÀüÀïÀº ¿©·¯ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý »ó½Â, °ø±Þ¸Á È¥¶õÀ» ÃÊ·¡ÇÏ¿© Á¦Ç° ¹× ¼­ºñ½º Àü¹Ý¿¡ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸ÄÑ ¼¼°è ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀåÀº CAGR 6.2%·Î ¼ºÀåÇÏ¿© ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2027³â¿¡´Â 2,461¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

2022³â ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ ÃÖ´ë Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå º¸°í¼­ÀÇ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, Áßµ¿ À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

ÀúºÐÀÚ ÀǾàǰ ¼ö¿ä Áõ°¡´Â ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ÀúºÐÀÚ ÀǾàǰÀº »ýÈ­ÇÐÀû °úÁ¤À» Á¶ÀýÇÏ¿© Áúº´À» Áø´Ü, Ä¡·á ¹× ¿¹¹æÇÒ ¼ö ÀÖ´Â ÀúºÐÀÚ È­ÇÕ¹°À» ¸»ÇÕ´Ï´Ù. ¾Æ½ºÇǸ°À̳ª µðÆæÈ÷µå¶ó¹Î µî ¾à »óÀÚ ¾È¿¡ µé¾î ÀÖ´Â ºÐÀÚ´Â ÀúºÐÀÚ ÀǾàǰÀÇ ÀÏ·ÊÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ºÐÀÚ ÀǾàǰÀº Áúº´ ¿¹¹æ¿¡ µµ¿òÀÌ µÇ´Â ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) Á¦Ç°À¸·Î ºÐ·ùµË´Ï´Ù. ¹Ì±¹ ±¹¸³ »ý¸í°øÇÐ Á¤º¸¼¾ÅÍ(NCBI)¿¡ µû¸£¸é 2021³â ½ÄǰÀǾ౹(FDA)ÀÌ ¼ö¿ëÇÑ ÀǾàǰÀÇ 75%°¡ ÀúºÐÀÚÀǾàǰÀ¸·Î Ä¡·á¿µ¿ªÀº Á¾¾çÇÐÀÌ ¾ÐµµÀûÀ̾ú½À´Ï´Ù. ÀÌ Áß 50% ÀÌ»óÀÌ Áß¼Ò±â¾÷¿¡ ÀÇÇÑ ½ÂÀÎÀ̸ç, CDMOÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â Á¦Ç°ÀÇ »ó¾÷È­¿¡´Â CDMO¿¡ ÀÇÇÑ Áö¿øÀÌ ÇÊ¿äÇÏ´Ù. µû¶ó¼­, ÀúºÐÀÚ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå Æ¯Â¡

Á¦3Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀåÀÇ µ¿Çâ°ú Àü·«

Á¦4Àå ¼ÒºÐÀÚ API ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
  • ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå¿¡ ´ëÇÑ ¿ìÅ©¶óÀ̳ª¿Í ·¯½Ã¾Æ ÀüÀïÀÇ ¿µÇâ
  • ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå¿¡ ´ëÇÑ °íÀÎÇ÷¹À̼ÇÀÇ ¿µÇâ

Á¦5Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Synthetic
  • Biotech
  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, Á¦Á¶¾÷üº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • In-House
  • Outsourced
  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â
  • ½ÉÀ庴ÇÐ
  • Á¾¾çÇÐ
  • ÁßÃ߽Űæ°è ¹× ½Å°æÇÐ
  • Á¤Çü¿Ü°ú
  • ³»ºÐºñÇÐ
  • ±âŸ ¿ëµµ

Á¦7Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀåÀÇ Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°èÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, ±ÔÁ¦, ±ÔÁ¦ ±â°ü, ÁÖ¿ä ´Üü, °ú¼¼µÇ´Â ¼¼±Ý, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦9Àå Áß±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • Áß±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • Áß±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F
  • Áß±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦10Àå ÀεµÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ÀεµÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀεµÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â

Á¦11Àå ÀϺ»ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ÀϺ»ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ»ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • È£ÁÖ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • Àεµ³×½Ã¾ÆÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F
  • Àεµ³×½Ã¾ÆÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â

Á¦14Àå Çѱ¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • Çѱ¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ¼­À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • ¼­À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ¿µ±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • µ¶ÀÏÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F
  • µ¶ÀÏÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ÇÁ¶û½ºÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F
  • ÇÁ¶û½ºÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â

Á¦19Àå µ¿À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • µ¿À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • µ¿À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾ÆÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ·¯½Ã¾ÆÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â
  • ·¯½Ã¾ÆÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â

Á¦21Àå ºÏ¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ºÏ¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • ºÏ¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027³â, 2032³â

Á¦22Àå ¹Ì±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ¹Ì±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • ¹Ì±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F
  • ¹Ì±¹ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦23Àå ³²¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ³²¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • ³²¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹ÌÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁúÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ºê¶óÁúÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁúÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022³â, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • Áßµ¿ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • Áßµ¿ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä«ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå

  • ¾ÆÇÁ¸®Ä«ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä«ÀÇ ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä« ¼ÒºÐÀÚ API ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå °æÀï ±¸µµ
  • ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Merck &Co., Inc.
    • AbbVie, Inc.
    • Bristol-Myers Squibb Company
    • Albemarle Corporation
    • Boehringer Ingelheim International GmbH

Á¦28Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦29Àå ÀúºÐÀÚ ¿ø·áÀǾàǰ(API) ½ÃÀå Àü¸Á°ú ÀáÀ缺 ºÐ¼®

Á¦30Àå ºÎ·Ï

LSH 23.05.02

“Small Molecule API Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule api market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule api? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The small molecule api market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Synthetic; Biotech
  • 2) By Manufacturer: In-House; Outsourced
  • 3) By Application: Cardiology; Oncology; CNS And Neurology; Orthopaedic; Endocrinology; Other Applications
  • Companies Mentioned: Merck & Co., Inc.; AbbVie, Inc.; Bristol-Myers Squibb Company; Albemarle Corporation; Boehringer Ingelheim International GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the small molecule api market are: Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Albemarle Corporation, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Aurobindo Pharma, Cambrex Corporation, Lonza, Siegfried AG, AstraZeneca, Hoffmann-La Roche Ltd., AND Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

The global small molecule API market is expected to grow from $180.67 billion in 2022 to $193.62 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The small molecule API market is expected to grow to $246.18 billion in 2027 at a CAGR of 6.2%.

The small molecules API market consists of sales of contract and captive small molecules API. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Small molecules API (active pharmaceutical ingredient) refers to organic components that have a low molecular weight of less than 1 nm and are typically made up of 20-100 atoms. These are active ingredients found in a wide range of biological and pharmaceutical procedures. Small molecules can be used as research tools to investigate biological function and to help develop new therapeutic agents. The small molecule API are used in pharmaceuticals and biological procedures.

North America was the largest region in the small molecule API market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule API market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of small molecule API include Synthetic and biotech. Synthetic refers to a molecule that has been synthesised in a laboratory using various chemical processes. The different small molecule API manufacturing include in-house and outsourced, used for applications in cardiology, oncology, CNS and neurology, orthopaedic, endocrinology and other applications.

The growing demand for small-molecule drugs is expected to propel the growth of the small-molecule API market. Small-molecule drugs refer to low-molecular-weight compounds that can modulate biochemical processes to diagnose, treat, or prevent disease. Aspirin, diphenhydramine, and other molecules commonly found in medicine cabinets are examples of small-molecule drugs. These molecule drug products come under the category of small molecule API products, which help in preventing disease. According to the National Center for Biotechnology Information (NCBI), in 2021, 75% of the drugs accepted by the Food and Drug Administration (FDA) were small molecules, with the dominant therapeutic area being oncology. Over 50% of these approvals were from small and mid-sized companies, which require support from CDMOs for the commercialization of products that contribute to the growth of CDMOs. Therefore, the growing demand for small-molecule drugs is driving the growth of the small-molecule API market.

Strategic partnership is a key trend in the small-molecule API market. Many companies operating in the small-molecule API market are undergoing partnerships to strengthen their position in the small-molecule API market and advance the development of various drugs and therapies. For instance, in December 2020, a US-based pharmaceutical and biotechnology company Pfizer Inc. partnered with a US-based machine learning medicinal chemistry company, PostEra. This partnership aims to accelerate small molecule drug discovery by developing a platform technology based on generative chemistry. Further, in January 2020, a US-based pharmaceutical company, Merck partnered with Japanese pharmaceutical company, Taiho Pharmaceutical Co., Ltd. This partnership aims to expand its focus on small-molecule inhibitors for cancer research.

In March 2022, GHO Capital, a European specialist investor in healthcare companies, acquired a majority stake in Sterling Pharma Solutions. With this acquisition, GHO Capital will facilitate the extensive sectoral pharmaceutical expertise in Europe and expand its market share in the U.S. Sterling Pharma Solutions is a US-based manufacturer of active pharmaceutical ingredients (APIs).

The countries covered in the Small Molecule API market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The small molecule API market research report is one of a series of new reports from The Business Research Company that provides small molecule API market statistics, including small molecule API industry global market size, regional shares, competitors with a small molecule API market share, detailed small molecule API market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule API industry. This small molecule API market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Small Molecule API Market Characteristics

3. Small Molecule API Market Trends And Strategies

4. Small Molecule API Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Small Molecule API Market
  • 4.2. Ukraine-Russia War Impact On Small Molecule API Market
  • 4.3. Impact Of High Inflation On Small Molecule API Market

5. Small Molecule API Market Size And Growth

  • 5.1. Global Small Molecule API Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Small Molecule API Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Small Molecule API Market Segmentation

  • 6.1. Global Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Synthetic
  • Biotech
  • 6.2. Global Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • In-House
  • Outsourced
  • 6.3. Global Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cardiology
  • Oncology
  • CNS And Neurology
  • Orthopaedic
  • Endocrinology
  • Other Applications

7. Small Molecule API Market Regional And Country Analysis

  • 7.1. Global Small Molecule API Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Small Molecule API Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Small Molecule API Market

  • 8.1. Asia-Pacific Small Molecule API Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Small Molecule API Market

  • 9.1. China Small Molecule API Market Overview
  • 9.2. China Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Small Molecule API Market

  • 10.1. India Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Small Molecule API Market

  • 11.1. Japan Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Small Molecule API Market

  • 12.1. Australia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Small Molecule API Market

  • 13.1. Indonesia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Small Molecule API Market

  • 14.1. South Korea Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Small Molecule API Market

  • 15.1. Western Europe Small Molecule API Market Overview
  • 15.2. Western Europe Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Small Molecule API Market

  • 16.1. UK Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Small Molecule API Market

  • 17.1. Germany Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Small Molecule API Market

  • 18.1. France Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Small Molecule API Market

  • 19.1. Eastern Europe Small Molecule API Market Overview
  • 19.2. Eastern Europe Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Small Molecule API Market

  • 20.1. Russia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Small Molecule API Market

  • 21.1. North America Small Molecule API Market Overview
  • 21.2. North America Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Small Molecule API Market

  • 22.1. USA Small Molecule API Market Overview
  • 22.2. USA Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Small Molecule API Market

  • 23.1. South America Small Molecule API Market Overview
  • 23.2. South America Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Small Molecule API Market

  • 24.1. Brazil Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Small Molecule API Market

  • 25.1. Middle East Small Molecule API Market Overview
  • 25.2. Middle East Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Small Molecule API Market

  • 26.1. Africa Small Molecule API Market Overview
  • 26.2. Africa Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Small Molecule API Market Competitive Landscape And Company Profiles

  • 27.1. Small Molecule API Market Competitive Landscape
  • 27.2. Small Molecule API Market Company Profiles
    • 27.2.1. Merck & Co., Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. AbbVie, Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol-Myers Squibb Company
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Albemarle Corporation
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Boehringer Ingelheim International GmbH
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Small Molecule API Market

29. Small Molecule API Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦